How Can We Predict Immunogenicity Earlier?

Identifying Potential Immune Responses Earlier in the Development of Biotherapeutics

Immunogenicity remains one of the key factors researchers must consider when developing a biologic drug, yet many R&D teams still rely on extensive physical testing to optimize it for a candidate. Predictive analytics can help researchers mine existing data to determine the key features that could impact immunogenicity for a given therapeutic, potentially laying out a more intelligent approach to designing the next generation of high-performance biologics. This white paper dives into the benefits and challenges facing this approach and can help you lay out the best course forward for your R&D team.